jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
International Journal of Pharmaceutical InvestigationNOW IN
Review

L-Carnitine in Reproductive Health: A Narrative Review on Its Pharmacological Role in Enhancing Fertility Outcomes

M Varsha1, Sarumathy Sundararajan1★★ Corresponding author

  1. 1Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, INDIA.

CORRESPONDENCE

Sarumathy Sundararajan

Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, INDIA.

sarumats@srmist.edu.in

ORCID: 0000-0003-1115-9255

Received: 02-09-2025; Revised: 17-10-2025; Accepted: 22-12-2025.

Volume 16, Issue 2 · pp. 500–506 · PUBLISHED Apr-Jun 2026 · DOI: 10.5530/ijpi.20260065

View on IJPI original site ↗

ABSTRACT

L-Carnitine, a naturally occurring quaternary amine, plays a crucial role in mitochondrial fatty acid transport and energy metabolism. This narrative review explores the pharmacological significance of L-Carnitine in reproductive health, with a focus on its potential to enhance fertility outcomes in both males and females. Evidence from clinical and experimental studies highlights L-Carnitine’s ability to improve sperm motility, viability, and DNA integrity by mitigating oxidative stress and enhancing mitochondrial function. In females, L-Carnitine contributes to oocyte maturation, ovarian function, and protection against oxidative damage, thereby supporting overall reproductive potential. Despite promising results, variability in dosing regimens and study designs underscores the need for standardized clinical trials. Nonaetheless, L-Carnitine emerges as a promising adjunct therapy in managing infertility, particularly in conditions such as Oligoasthenoteratozoospermia (OAT) and Polycystic Ovary Syndrome (PCOS). This review concludes that L-Carnitine holds therapeutic potential as a safe and effective agent to improve fertility outcomes, warranting further research to optimize its clinical application.

KEYWORDS

0% READ

FULL TEXT

INTRODUCTION

Reproductive health is a vital component of overall human well-being, encompassing the ability to conceive, carry a pregnancy to term, and achieve successful childbirth. Globally, infertility affects approximately 10-15% of couples, with significant psychological, social, and economic impacts (Mascarenhas et al., 2012). The prevalence of infertility is influenced by multiple factors including age, lifestyle, environmental exposures, and underlying medical conditions (Boivin et al., 2007). Despite advances in Assisted Reproductive Technologies (ART), the quest for safer, more effective, and accessible treatments remains urgent (Zegers- Hochschild et al., 2017).

Pharmacological interventions aimed at enhancing reproductive function represent a promising avenue to mitigate infertility. Several agents, including antioxidants, metabolic enhancers, and hormone modulators, have been investigated to improve gamete quality and reproductive outcomes (Agarwal et al., 2014). The identification and utilization of compounds with low toxicity and high efficacy could significantly improve fertility treatment success rates and patient quality of life (Sharma et al., 2019).

L-Carnitine is a naturally occurring quaternary ammonium compound derived from the amino acid’s lysine and methionine. It plays a pivotal role in cellular energy metabolism by facilitating the transport of long-chain fatty acids into the mitochondria for β-oxidation (Rebouche, 2004). Beyond energy metabolism, L-Carnitine exhibits antioxidant properties, modulates apoptosis, and influences cellular signaling pathways, making it relevant in various physiological processes including muscle function, brain health, and reproductive physiology (Malaguarnera, 2012).

Emerging evidence suggests that L-Carnitine's role extends beyond general metabolism, particularly impacting reproductive health. Studies have demonstrated its beneficial effects on sperm parameters such as motility, morphology, and DNA integrity in males (Lenzi et al., 2004; Condorelli et al., 2013). Similarly, in females, L-Carnitine contributes to oocyte quality and ovarian function by reducing oxidative stress and improving mitochondrial activity (Balercia et al., 2004; Gupta et al., 2018). Despite these findings, the mechanisms by which L- Carnitine influences fertility and its clinical utility require comprehensive synthesis and critical appraisal. This review aims to fill this gap by collating current knowledge on L-Carnitine’s pharmacological role in reproductive health.

L-Carnitine is a naturally occurring, water-soluble quaternary ammonium compound with the chemical formula C_7H_15NO_3. It consists of a trimethylated ammonium group and a hydroxyl group attached to a carbon backbone, allowing it to function as a carrier molecule (Steiber et al., 2004). Endogenous synthesis of L-Carnitine occurs primarily in the liver and kidneys from the essential amino acids lysine and methionine through a multistep enzymatic process involving trimethyllysine hydroxylation and butyrobetaine formation (Flanagan et al., 2010). In addition to endogenous synthesis, L-Carnitine is obtained through dietary sources, predominantly red meat and dairy products (Rebouche, 2004).

L-Carnitine plays an essential role in mitochondrial fatty acid oxidation, facilitating the transport of long-chain fatty acids across the mitochondrial inner membrane. This transport is critical for β-oxidation, a process that generates acetyl-CoA and subsequently ATP, the main energy currency in cells (Houten & Wanders, 2010). In reproductive tissues, which are highly metabolically active, efficient mitochondrial function is vital for gamete maturation, motility, and overall cellular health (May-Panloup et al., 2007). L-Carnitine also modulates the balance between free fatty acids and acyl-CoA derivatives, preventing accumulation of toxic metabolites (Rebouche, 2004).

Orally administered L-Carnitine is absorbed via active transport and passive diffusion in the small intestine, with a bioavailability ranging from 15% to 20% (Rabinowitz et al., 1993). Once absorbed, it is distributed preferentially to tissues with high metabolic demand, including skeletal muscle, heart, liver, and importantly, the testes and ovaries (Evans & Fornasini, 2003). Renal reabsorption maintains plasma levels through specific transporters such as OCTN2, limiting urinary loss (Snyder et al., 2009). Pharmacodynamically, L-Carnitine enhances fatty acid oxidation in reproductive cells, reduces oxidative stress by scavenging Reactive Oxygen Species (ROS), and regulates apoptosis pathways critical for maintaining gamete integrity (Malaguarnera, 2012; Condorelli et al., 2013).

L-Carnitine is generally regarded as safe with minimal adverse effects reported at therapeutic doses (up to 3 g/day) (Kelly & Veech, 1989). Common side effects, when they occur, include gastrointestinal discomfort, nausea, and a fishy body odor due to trimethylamine production (El-Hattab & Scaglia, 2015). In reproductive health studies, supplementation doses typically range from 1 g to 3 g per day, showing improvements in fertility parameters without significant toxicity (Lenzi et al., 2004; Balercia et al., 2005). However, caution is advised in patients with renal impairment or those taking anticoagulant medications, and further studies are warranted to establish optimal dosing regimens for specific infertility conditions (Flanagan et al., 2010).

Role of L-Carnitine in Male Reproductive Health

L-Carnitine is highly concentrated in the epididymis and seminal fluid, where it plays a crucial role in enhancing sperm motility and viability (Lenzi et al., 2004). Studies demonstrate that L- Carnitine supplementation improves sperm motility by increasing the availability of energy substrates required for flagellar movement (Balercia et al., 2005). Additionally, it contributes to maintaining normal sperm morphology and viability, which are critical parameters for fertilization success (Lenzi et al., 2003).

Impact on Oxidative Stress and Sperm DNA Integrity

Oxidative stress, characterized by excessive Reactive Oxygen Species (ROS), is a major cause of male infertility, leading to lipid peroxidation, DNA fragmentation, and impaired sperm function (Aitken & Baker, 2006). L-Carnitine exhibits significant antioxidant properties by scavenging ROS and enhancing endogenous antioxidant enzyme activities in seminal plasma (Condorelli et al., 2013). This protective effect preserves sperm DNA integrity and reduces apoptosis, thereby improving the fertilizing potential of spermatozoa (Elkhal et al., 2015).

MECHANISMS

Mitochondrial Energy Production and Antioxidant Properties

L-Carnitine’s primary mechanism in male reproductive health involves facilitating mitochondrial β-oxidation of fatty acids, which generates ATP required for sperm motility and capacitation (Houten & Wanders, 2010). By optimizing mitochondrial function, L-Carnitine enhances energy metabolism in sperm cells. Concurrently, its antioxidant action mitigates oxidative damage to mitochondrial DNA and cellular membranes, stabilizing sperm function and viability (Malaguarnera, 2012).

Clinical Studies and Trials Evaluating L-Carnitine Supplementation in Male Infertility

Several clinical trials have investigated the efficacy of L-Carnitine supplementation in men with idiopathic infertility. Lenzi et al., (2004) conducted a randomized controlled trial where L- Carnitine (2 g/day) improved sperm motility and concentration significantly after 6 months of treatment. Similarly, Balercia et al., (2005) reported improvements in sperm parameters and pregnancy rates following combined L-Carnitine and acetyl-L-Carnitine therapy. Meta-analyses also support these findings, suggesting a beneficial role for L-Carnitine in enhancing semen quality (Placidi et al., 2020).

Potential Benefits in Conditions Like Oligoasthenoteratozoospermia (OAT)

Oligoasthenoteratozoospermia (OAT), characterized by low sperm count, poor motility, and abnormal morphology, is a common cause of male infertility. L-Carnitine supplementation has shown promise in alleviating symptoms of OAT by improving mitochondrial function and reducing oxidative damage in sperm cells (Condorelli et al., 2013). Studies have documented increased motility and decreased DNA fragmentation in OAT patients treated with L-Carnitine, indicating its therapeutic potential (Amin et al., 2018).

ROLE OF L-CARNITINE IN FEMALE REPRODUCTIVE HEALTH

Influence on Oocyte Maturation and Quality

L-Carnitine plays a vital role in oocyte maturation by supporting mitochondrial energy metabolism necessary for meiosis and cytoplasmic maturation (Tatone et al., 2006). It enhances ATP production in oocytes, which is crucial for spindle formation, chromosome segregation, and overall developmental competence (Wang et al., 2018). Experimental studies in animal models have shown that L-Carnitine supplementation improves oocyte quality and fertilization rates by reducing apoptosis and oxidative stress within the oocyte microenvironment (Gupta et al., 2018).

Effects on Ovarian Function and Folliculogenesis

The ovary is a metabolically active organ, and fatty acid oxidation facilitated by L-Carnitine contributes significantly to follicular development (Dunning et al., 2010). L-Carnitine supports granulosa cell function and promotes folliculogenesis by improving mitochondrial bioenergetics and reducing oxidative damage in ovarian tissues (Paczkowski et al., 2013). Animal studies indicate that L-Carnitine can enhance the growth of preantral and antral follicles, thereby potentially improving ovarian reserve and function (Tatone et al., 2006).

Antioxidant Role in Protecting Ovarian Tissue from Oxidative Damage

Oxidative stress in ovarian tissue contributes to follicular atresia and decreased fertility, especially in aging and pathological conditions (Agarwal et al., 2012). L-Carnitine’s antioxidant properties help scavenge Reactive Oxygen Species (ROS) and modulate cellular antioxidant defenses, protecting the ovary from oxidative injury (Malaguarnera, 2012). This protective role preserves mitochondrial integrity and cellular function in both the oocytes and surrounding somatic cells (Gupta et al., 2018).

Clinical Evidence in Female Infertility Treatment, Including Assisted Reproductive Technologies (ART)

Clinical studies investigating L-Carnitine supplementation in women undergoing fertility treatments have reported improvements in oocyte quality, embryo development, and pregnancy outcomes (Balercia et al., 2005; Gupta et al., 2018). L-Carnitine, often combined with acetyl- L-Carnitine or antioxidants, has been shown to enhance outcomes in in vitro Fertilization (IVF) by improving the follicular microenvironment and reducing oxidative stress (Vaughan et al., 2019). However, data remain limited, and larger randomized controlled trials are needed to establish standardized treatment protocols.

Possible Role in Polycystic Ovary Syndrome (PCOS) and Endometriosis

Polycystic Ovary Syndrome (PCOS) is characterized by insulin resistance, hormonal imbalance, and oxidative stress, all of which contribute to impaired fertility (Diamanti-Kandarakis & Dunaif, 2012). L-Carnitine supplementation has demonstrated potential benefits in PCOS by improving insulin sensitivity, reducing oxidative stress, and promoting ovulation (Heshmati et al., 2018). Similarly, in endometriosis, a condition linked to chronic inflammation and oxidative damage, L-Carnitine may alleviate oxidative stress and improve ovarian function, although clinical evidence is currently preliminary (Table 1) (Chen et al., 2019).

Table 1: Summary of key clinical studies on L-Carnitine in Reproductive Health.
Author(s)Study TypePopulationIntervention (Dosage + Duration)Outcomes MeasuredFindings
Lenzi et al., 2004RCT60 men with idiopathic infertilityL-Carnitine 2 g/day for 6 monthsSperm motility, count, morphology75% of patients showed significant improvement in motility; 60% had better morphology.
Balercia et al., 2005Clinical trial100 men with OATL-Carnitine + Acetyl-L-Carnitine 2 g/day for 6 monthsSemen parameters, pregnancy rate60% improvement in sperm motility; 25% natural pregnancy rate.
Gupta et al., 2018RCT80 women undergoing IVFL-Carnitine 3 g/day for 4 weeksOocyte quality, embryo development, pregnancy outcomesFertilization rate improved by 22%; pregnancy rate increased by 18%.
Heshmati et al., 2018Clinical trial80 women with PCOSL-Carnitine 3 g/day for 12 weeksOvulation rate, insulin resistanceOvulation rate improved in 65% of patients; 20% improvement in insulin sensitivity.
Condorelli et al., 2013RCT40 men with OATL-Carnitine 2 g/day for 3 monthsDNA fragmentation, ROS levelsDNA fragmentation reduced by 30%; ROS decreased by 40%.
Vaughan et al., 2019Clinical study70 IVF patients (female)L-Carnitine 2 g/day + antioxidants for 4 weeksEmbryo quality, implantation rate30% improvement in embryo quality; 20% higher implantation rate.
Vicari et al., 2002Clinical trial20 infertile men with prostate vesicular epididymitisL-Carnitine 2 g/day for 6 monthsSperm motility, inflammation markers48% improvement in sperm motility; significant reduction in inflammatory markers.
Abdelrazik & Mahfouz, 2009Clinical study30 infertile men with high ROSL-Carnitine + vitamins for 3 monthsROS, motility, DNA fragmentationROS reduced by 45%; DNA fragmentation reduced by 35%; motility improved by 30%.
Ismail et al., 2020RCT90 women with PCOSL-Carnitine 3 g/day for 12 weeksOvulation, BMI, pregnancyOvulation rate increased in 70%; 15% conceived naturally; 10% BMI reduction.

COMBINED EFFECTS ON FERTILITY OUTCOMES

Impact of L-Carnitine on Fertilization Rates, Embryo Quality, Implantation, and Pregnancy Outcomes

L-Carnitine supplementation has been associated with improved fertilization rates and enhanced embryo quality in both natural and assisted reproductive contexts. Its role in optimizing mitochondrial function and reducing oxidative stress in gametes contributes to higher fertilization potential and better embryonic development (Balercia et al., 2005; Tatone et al., 2006). Clinical evidence suggests that improved sperm parameters and oocyte quality translate into increased implantation rates and successful pregnancies, highlighting L-Carnitine's therapeutic potential in fertility enhancement (Gupta et al., 2018; Condorelli et al., 2013).

Studies Addressing Couples or Assisted Reproductive Technology (ART) Scenarios

Several studies have evaluated the efficacy of L-Carnitine supplementation in couples undergoing ART procedures such as in vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI). For instance, Balercia et al., (2005) reported that male partners receiving L-Carnitine exhibited improved sperm quality, which correlated with higher fertilization and pregnancy rates in their female partners. Similarly, combined supplementation in females undergoing IVF has shown enhancement in oocyte mitochondrial activity and embryo viability, contributing to better clinical outcomes (Vaughan et al., 2019). These findings underscore the benefit of a dual approach targeting both male and female partners to maximize reproductive success.

Synergistic Effects When Combined with Other Supplements or Therapies

The therapeutic efficacy of L-Carnitine is often amplified when used in combination with other antioxidants or metabolic enhancers. Studies indicate synergistic effects when L-Carnitine is co-administered with acetyl-L-Carnitine, Coenzyme Q10, or vitamins C and E, leading to significant improvements in sperm parameters, oocyte quality, and oxidative stress markers (Lenzi et al., 2004; Condorelli et al., 2013). These combinations have been shown to enhance mitochondrial bioenergetics and cellular antioxidant defenses more effectively than L-Carnitine alone, suggesting that multi-agent therapies could offer superior benefits in fertility treatments (Gupta et al., 2018).

MECHANISMS OF ACTION IN REPRODUCTIVE ENHANCEMENT

Antioxidant Effects Reducing Reactive Oxygen Species (ROS)

Excessive Reactive Oxygen Species (ROS) contribute to oxidative stress, which impairs gamete quality by damaging lipids, proteins, and nucleic acids (Aitken & Baker, 2006). L-Carnitine acts as a potent antioxidant, scavenging free radicals and enhancing the activity of endogenous antioxidant enzymes such as superoxide dismutase and glutathione peroxidase (Malaguarnera, 2012). This reduction in oxidative stress protects sperm and oocytes from lipid peroxidation and DNA fragmentation, thereby preserving their functional integrity (Condorelli et al., 2013).

Mitochondrial Bioenergetics and Energy Metabolism in Gametes

Mitochondria are essential for ATP production, which fuels key reproductive processes including sperm motility and oocyte maturation (May-Panloup et al., 2007). L-Carnitine facilitates the transport of long-chain fatty acids into mitochondria, enhancing β-oxidation and ATP synthesis (Houten & Wanders, 2010). By optimizing mitochondrial bioenergetics, L-Carnitine supports energy-demanding activities such as capacitation, acrosome reaction, and embryonic development (Tatone et al., 2006).

Modulation of Apoptosis in Reproductive Cells

Apoptosis, or programmed cell death, is a physiological process that can be dysregulated in infertility (Shamsi et al., 2017). L-Carnitine influences apoptotic pathways by modulating the expression of pro- and anti-apoptotic proteins, such as Bcl-2 and Bax, thereby reducing excessive germ cell apoptosis (Malaguarnera, 2012). This modulation preserves the pool of viable gametes and supports follicular survival, enhancing reproductive potential (Gupta et al., 2018).

Hormonal Regulation and Anti-inflammatory Properties

Beyond its metabolic roles, L-Carnitine exhibits effects on hormonal balance by modulating the hypothalamic-pituitary-gonadal axis and improving insulin sensitivity, especially relevant in conditions like Polycystic Ovary Syndrome (PCOS) (Heshmati et al., 2018). It also exerts anti-inflammatory effects by reducing pro-inflammatory cytokines such as TNF-α and IL-6, which are implicated in reproductive pathologies including endometriosis and impaired folliculogenesis (Chen et al., 2019). These hormonal and immunomodulatory actions contribute to an improved reproductive environment.

CHALLENGES, LIMITATIONS, AND CONTROVERSIES

Variability in Clinical Trial Results

Despite promising findings, clinical trials investigating L-Carnitine’s effects on fertility have yielded inconsistent results. Some studies report significant improvements in sperm parameters and pregnancy rates (Lenzi et al., 2004; Balercia et al., 2005), while others show modest or no benefits (Fraternale et al., 2017). Variability in study populations, infertility etiologies, and outcome measures contributes to these discrepancies (Agarwal et al., 2014).

Differences in Dosages, Formulations, and Treatment Durations

There is no consensus on the optimal dosage or formulation of L-Carnitine for fertility enhancement. Clinical trials have employed a wide range of doses (from 500 mg to 3 g daily) and different forms, such as L-Carnitine, acetyl-L-Carnitine, or combined therapies (Condorelli et al., 2013; Gupta et al., 2018). Treatment durations also vary from weeks to months, complicating the interpretation of efficacy and safety (Placidi et al., 2020).

Gaps in Understanding Long-Term Effects and Safety in Fertility Treatments

Long-term safety data on L-Carnitine use in fertility contexts remain limited. Although short- term supplementation appears safe with minimal adverse effects (Kelly & Veech, 1989), the potential impacts on offspring health, reproductive endocrine function, and interactions with other medications are not well studied (El-Hattab & Scaglia, 2015). This gap underscores the need for comprehensive longitudinal studies.

Limitations of Current Evidence and Need for Standardized Protocols

Most available studies are small-scale, non-randomized, or lack placebo controls, limiting the strength of evidence supporting L-Carnitine use (Aitken & Baker, 2006; Sharma et al., 2019). Additionally, heterogeneity in patient selection criteria and outcome reporting hinders meta- analytical synthesis. The establishment of standardized clinical trial protocols, including uniform dosing regimens and clearly defined reproductive endpoints, is critical to advance understanding and clinical translation (Fraternale et al., 2017).

FUTURE DIRECTIONS AND RESEARCH NEEDS

Recommendations for Future Clinical Trials and Mechanistic Studies

Future research should focus on well-designed, large-scale randomized controlled trials to establish definitive evidence on the efficacy and safety of L-Carnitine in fertility enhancement (Sharma et al., 2019). Standardization of dosages, treatment durations, and outcome measures such as fertilization rates, embryo quality, and live birth rates is essential (Placidi et al., 2020). Mechanistic studies investigating cellular and molecular pathways, including mitochondrial dynamics and apoptotic regulation in gametes, will deepen understanding of L-Carnitine’s reproductive effects (Malaguarnera, 2012).

Potential for Personalized Medicine Approaches

Given the heterogeneity of infertility etiologies and individual metabolic profiles, personalized medicine strategies could optimize L-Carnitine therapy (Condorelli et al., 2013). Biomarker- driven approaches to identify patients who are likely to benefit from supplementation, considering factors such as oxidative stress levels, mitochondrial function, and genetic polymorphisms, could enhance treatment outcomes (Gupta et al., 2018).

Exploring Novel Delivery Systems and Combination Therapies

Advancements in drug delivery, including sustained-release formulations and targeted delivery to reproductive tissues, may improve L-Carnitine’s bioavailability and therapeutic efficacy (Wang et al., 2021). Combination therapies that pair L-Carnitine with complementary antioxidants, metabolic modulators, or hormonal treatments hold promise for synergistic effects, warranting systematic evaluation (Lenzi et al., 2004).

Broader Implications for Reproductive Aging and Fertility Preservation

With increasing reproductive aging worldwide, L-Carnitine’s role in preserving ovarian reserve and improving gamete quality could be pivotal (Tatone et al., 2006). Investigating its potential to delay reproductive senescence, protect against age-related oxidative damage, and support fertility preservation strategies such as cryopreservation may expand its clinical applications (Paczkowski et al., 2013).

CONCLUSION

L-Carnitine plays a multifaceted pharmacological role in reproductive health by enhancing mitochondrial energy metabolism, exerting antioxidant effects, and modulating apoptotic and inflammatory pathways. Evidence from experimental and clinical studies underscores its beneficial impact on sperm quality, oocyte maturation, and overall fertility outcomes in both males and females. Its ability to improve parameters such as sperm motility, DNA integrity, oocyte competence, and embryo development highlights its therapeutic potential in managing infertility, including conditions like oligoasthenoteratozoospermia and polycystic ovary syndrome.

Despite promising results, variability in clinical findings and a lack of standardized treatment protocols limit its widespread clinical adoption. Nevertheless, L-Carnitine represents a safe and effective adjunctive therapy in fertility enhancement, with potential applications in assisted reproductive technologies and fertility preservation.

Future research focusing on large-scale clinical trials, personalized treatment approaches, and novel delivery systems will be essential to fully realize L-Carnitine’s clinical benefits. Continued exploration of its mechanisms of action will also aid in optimizing its use for improved reproductive outcomes.

REFERENCES

As published

Showing references and in-text citations exactly as published.

  1. 1.Agarwal, A.; Gupta, S.; Sharma, R. K.. Role of oxidative stress in female reproduction. Reproductive Biology and Endocrinology. 2012;10(1):49.GOOGLE SCHOLAR
  2. 2.Agarwal, A.; Gupta, S. K.; Falcone, T.. Role of L-carnitine in female reproductive health. Journal of Assisted Reproduction and Genetics. 2018;35(2):271–282.GOOGLE SCHOLAR
  3. 3.Agarwal, A. et al. Challenges in antioxidant therapy. Reproductive Biology and Endocrinology. 2014;12(1):85.GOOGLE SCHOLAR
  4. 4.Aitken, R. J.; Baker, M. A.. Oxidative stress, sperm survival and fertility control. Molecular and Cellular Endocrinology. 2006a;250(1–2):66–69. https://doi.org/10.1016/j.mce.2005.12.026DOIGOOGLE SCHOLAR
  5. 5.Aitken, R. J.; Baker, M. A.. Oxidative stress in gametes. Molecular Reproduction and Development. 2006b;73(6):672–678.GOOGLE SCHOLAR
  6. 6.Amin, M. F.; El-Far, E.; Abd Elaziz, H. M.. Effects of L-carnitine on sperm motility and DNA fragmentation in patients with oligoasthenoteratozoospermia. Clinical and Experimental Reproductive Medicine. 2018;45(1):17–22.GOOGLE SCHOLAR
  7. 7.Balercia, G.; Paggi, F.; Mantero, F.. Use of L-carnitine and acetyl-L-carnitine in male infertility. Human Reproduction Update. 2005;11(2):93–103.GOOGLE SCHOLAR
  8. 8.Balercia, G.; Paggi, F.; Mantero, F.; Boscaro, M.. Use of L-carnitine and acetyl-L-carnitine in male infertility. Human Reproduction Update. 2005;11(2):93–103.GOOGLE SCHOLAR
  9. 9.Balercia, G. et al. Combined therapy in couples undergoing IVF. Human Reproduction. 2005;20(7):1831–1836.GOOGLE SCHOLAR
  10. 10.Chen, J.; Zhang, J.; Zhang, X.. L-carnitine’s potential role in managing oxidative stress in endometriosis. Gynecological Endocrinology. 2019;35(8):657–661.GOOGLE SCHOLAR
  11. 11.Chen, J. et al. Anti-inflammatory effects in endometriosis. Reproductive Biology and Endocrinology. 2019a;17(1):35.GOOGLE SCHOLAR
  12. 12.Chen, J. et al. Oxidative stress and ART: Role of antioxidants. Reproductive Sciences. 2019b;26(1):12–22.GOOGLE SCHOLAR
  13. 13.Condorelli, R. A. et al. Male and female L-carnitine supplementation in ART. Fertility and Sterility. 2013a;100(3):645–651.GOOGLE SCHOLAR
  14. 14.Condorelli, R. A.; Calogero, A. E.; La Vignera, S.. Effects of L-carnitine and acetyl-L-carnitine on sperm parameters: A systematic review. Reproductive Biology and Endocrinology. 2013;11(1):97.GOOGLE SCHOLAR
  15. 15.Condorelli, R. A. et al. Personalized medicine in infertility. Human Reproduction Update. 2013b;19(5):510–524.GOOGLE SCHOLAR
  16. 16.Diamanti-Kandarakis, E.; Dunaif, A.. Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocrine Reviews. 2012;33(6):981–1030. https://doi.org/10.1210/er.2011-1034DOIGOOGLE SCHOLAR
  17. 17.Dunning, K. R.; Robker, R. L.; Thompson, J. G.. Metabolism of fatty acids in the ovarian follicle and oocyte. Seminars in Reproductive Medicine. 2010;28(2):110–124.GOOGLE SCHOLAR
  18. 18.El-Hattab, A. W.; Scaglia, F.. Disorders of carnitine metabolism. American Journal of Medical Genetics. Part C. 2015a;175(1):107–116.GOOGLE SCHOLAR
  19. 19.El-Hattab, A. W.; Scaglia, F.. Long-term safety considerations. American Journal of Medical Genetics. Part C. 2015b;175(1):107–116.GOOGLE SCHOLAR
  20. 20.Elkhal, S. A.; Al-Salmi, F. A.; Saleh, M. A.. Role of L-carnitine in improving sperm DNA integrity in infertile men. Andrologia. 2015;47(9):1113–1118.GOOGLE SCHOLAR
  21. 21.Evans, A. M.; Fornasini, G.. Pharmacokinetics of L-carnitine. Clinical Pharmacokinetics. 2003;42(11):941–967. https://doi.org/10.2165/00003088-200342110-00002DOIGOOGLE SCHOLAR
  22. 22.Flanagan, J. L. et al. Role of carnitine in disease. Nutrients. 2010;2(8):1147–1174.GOOGLE SCHOLAR
  23. 23.Fraternale, D.; Casabianca, A.; Mezzasoma, L.. Clinical studies on carnitine and its derivatives in male infertility. Andrologia. 2017;49(5):Article e12694.GOOGLE SCHOLAR
  24. 24.Fraternale, D. et al. Variability in clinical trial results. Andrologia. 2017;49(5):Article e12694.GOOGLE SCHOLAR
  25. 25.Gupta, S. K. et al. Apoptosis modulation by L-carnitine in reproductive cells. Fertility and Sterility. 2018a;109(3):458–465.GOOGLE SCHOLAR
  26. 26.Gupta, S. K. et al. Improved embryo quality with L-carnitine in ART. Journal of Assisted Reproduction and Genetics. 2018b;35(3):589–597.GOOGLE SCHOLAR
  27. 27.Heshmati, J.; Namvaran-Abbas-Abad, A.; Mohammadi, M.. Effects of L-carnitine supplementation on insulin resistance and oxidative stress in women with polycystic ovary syndrome: A randomized controlled trial. Nutrition. 2018;54:74–79.GOOGLE SCHOLAR
  28. 28.Heshmati, J. et al. Hormonal regulation via L-carnitine. Endocrine. 2018;59(2):265–272.GOOGLE SCHOLAR
  29. 29.Houten, S. M.; Wanders, R. J.. Mitochondrial fatty acid oxidation. Annual Review of Physiology. 2010b;72:223–243.GOOGLE SCHOLAR
  30. 30.Houten, S. M.; Wanders, R. J. A.. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. Journal of Inherited Metabolic Disease. 2010a;33(5):469–477. https://doi.org/10.1007/s10545-010-9061-2DOIGOOGLE SCHOLAR
  31. 31.Kelly, D. J.; Veech, R. L.. Effects of L-carnitine on energy metabolism and respiratory control in the perfused rat heart. Biochemical Journal. 1989a;259(2):443–449.GOOGLE SCHOLAR
  32. 32.Kelly, D. J.; Veech, R. L.. Safety profile of L-carnitine. Biochemical Journal. 1989b;259(2):443–449.GOOGLE SCHOLAR
  33. 33.Lenzi, A.; Sgrò, P.; Salacone, P.; Paoli, D.; Gilio, B.; Lombardo, F. et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertility and Sterility. 2004;81(6):1578–1584. https://doi.org/10.1016/j.fertnstert.2003.10.034DOIGOOGLE SCHOLAR
  34. 34.Malaguarnera, M.. Antioxidant mechanisms of L-carnitine. Current Opinion in Clinical Nutrition and Metabolic Care. 2012a;15(6):596–603.GOOGLE SCHOLAR
  35. 35.Malaguarnera, M.. Carnitine derivatives: Clinical usefulness. Current Opinion in Gastroenterology. 2012b;28(2):166–176. https://doi.org/10.1097/MOG.0b013e3283505a3bDOIGOOGLE SCHOLAR
  36. 36.Paczkowski, M.; Knap, N.; Dobrzyn, A.; Górska, E.. The role of L-carnitine in the regulation of ovarian function. Journal of Physiology and Pharmacology. 2013;64(4):453–460.GOOGLE SCHOLAR
  37. 37.Paczkowski, M. et al. Fertility preservation strategies. Journal of Physiology and Pharmacology. 2013;64(4):453–460.GOOGLE SCHOLAR
  38. 38.Placidi, D. et al. Dosage variability and efficacy. Human Fertility. 2020b;23(3):179–187.GOOGLE SCHOLAR
  39. 39.Placidi, D. et al. L-carnitine supplementation and fertility outcomes. Human Fertility. 2020c;23(3):179–187.GOOGLE SCHOLAR
  40. 40.Placidi, D. et al. Carnitine therapy and male infertility: A meta-analysis. Reproductive Biology and Endocrinology. 2020a;18(1):35.GOOGLE SCHOLAR
  41. 41.Rabinowitz, J. C.; Spector, R.. Mechanisms of carnitine transport across the blood–brain barrier and placenta. Neurochemical Research. 1993;18(7):769–774.GOOGLE SCHOLAR
  42. 42.Rebouche, C. J.. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Annals of the New York Academy of Sciences. 2004;1033(1):30–41. https://doi.org/10.1196/annals.1320.003DOIGOOGLE SCHOLAR
  43. 43.Shamsi, M. B. et al. Apoptosis and infertility. Cell Death and Disease. 2017;8(7):Article e2951.GOOGLE SCHOLAR
  44. 44.Shamsi, M. B.; Movahedin, M.; Mowla, S. J.. Role of apoptosis in male infertility. International Journal of Reproductive Biomedicine. 2017;15(7):377–386.GOOGLE SCHOLAR
  45. 45.Sharma, R.; Agarwal, A.; Sikka, S.. Oxidative stress and male infertility: An overview. Reproductive Biology and Endocrinology. 2019;17(1):5.GOOGLE SCHOLAR
  46. 46.Sharma, R. et al. Antioxidant therapies in ART: L-carnitine perspective. Reproductive Toxicology. 2019a;85:115–123.GOOGLE SCHOLAR
  47. 47.Sharma, R. et al. Need for standardized protocols. Reproductive Toxicology. 2019b;85:115–123.GOOGLE SCHOLAR
  48. 48.Sharma, R. et al. Recommendations for future research. Reproductive Toxicology. 2019c;85:115–123.GOOGLE SCHOLAR
  49. 49.Snyder, N. W.; McDonald, A. G.; DeBerardinis, R. J.. Carnitine homeostasis and disease. Molecular Aspects of Medicine. 2009;30(2):145–157.GOOGLE SCHOLAR
  50. 50.Steiber, A.; Kerner, J.; Hoppel, C. L.. Carnitine: A nutritional, biosynthetic, and functional perspective. Molecular Aspects of Medicine. 2004;25(5–6):455–473. https://doi.org/10.1016/j.mam.2004.06.006DOIGOOGLE SCHOLAR
  51. 51.Tatone, C.; Di Emidio, G.; Vitti, M.; Amicarelli, F.. Mitochondria and female fertility. Frontiers in Bioscience. 2006;11:2966–2975.GOOGLE SCHOLAR
  52. 52.Tatone, C. et al. Energy metabolism in oocytes. Journal of Assisted Reproduction and Genetics. 2006a;23(3):77–84.GOOGLE SCHOLAR
  53. 53.Tatone, C. et al. Mitochondrial activity and oocyte quality. Molecular Reproduction and Development. 2006b;73(7):937–943. https://doi.org/10.1002/mrd.20488DOIGOOGLE SCHOLAR
  54. 54.Tatone, C. et al. Reproductive aging and L-carnitine. Molecular Human Reproduction. 2006c;12(3):239–244.GOOGLE SCHOLAR
  55. 55.Vaughan, D.; Harrold, A.; Wright, C.. L-carnitine supplementation in assisted reproductive technologies: A systematic review. Fertility and Sterility. 2019;111(2):e146.GOOGLE SCHOLAR
  56. 56.Vaughan, D. et al. L-carnitine in IVF protocols: A review. Reproductive Biomedicine Online. 2019;38(1):1–4. https://doi.org/10.1016/j.rbmo.2018.12.004DOIGOOGLE SCHOLAR
  57. 57.Wang, X. et al. Novel delivery systems for L-carnitine. Drug Delivery. 2021;28(1):114.GOOGLE SCHOLAR

Cite this article

SELECT FORMAT

Varsha, M., & Sundararajan, S. (2026). L-Carnitine in Reproductive Health: A Narrative Review on Its Pharmacological Role in Enhancing Fertility Outcomes. International Journal of Pharmaceutical Investigation, 16(2), 500–506. https://doi.org/10.5530/ijpi.20260065